These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6416860)

  • 1. Portal-systemic spill-over of bile acids: a study of mechanisms using ursodeoxycholic acid.
    Miescher G; Paumgartner G; Preisig R
    Eur J Clin Invest; 1983 Dec; 13(6):439-45. PubMed ID: 6416860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration.
    Nakagawa M; Colombo C; Setchell KD
    Hepatology; 1990 Aug; 12(2):322-34. PubMed ID: 2391071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bile acid glycine and taurine conjugates in serum of patients with primary biliary cirrhosis: effect of ursodeoxycholic treatment.
    Chretien Y; Poupon R; Gherardt MF; Chazouilleres O; Labbe D; Myara A; Trivin F
    Gut; 1989 Aug; 30(8):1110-5. PubMed ID: 2767508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase of sulfated ursodeoxycholic acid in the serum and urine of patients with chronic liver disease after ursodeoxycholic acid therapy.
    Nakamura K; Yoneda M; Kimura A; Tamori K; Yokohama S; Sato Y; Kato T; Hasegawa T; Saito H; Aoshima M; Fujita M; Makino I
    J Gastroenterol Hepatol; 1996 Apr; 11(4):385-90. PubMed ID: 8713707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentrations of ursodeoxycholic acid in portal venous and systemic venous blood of fasting humans as determined by isotope dilution-mass spectrometry.
    Ewerth S; Angelin B; Einarsson K; Nilsell K; Björkhem I
    Gastroenterology; 1985 Jan; 88(1 Pt 1):126-33. PubMed ID: 3880555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid.
    Combes B; Carithers RL; Maddrey WC; Munoz S; Garcia-Tsao G; Bonner GF; Boyer JL; Luketic VA; Shiffman ML; Peters MG; White H; Zetterman RK; Risser R; Rossi SS; Hofmann AF
    Hepatology; 1999 Jun; 29(6):1649-54. PubMed ID: 10347103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis.
    Colombo C; Setchell KD; Podda M; Crosignani A; Roda A; Curcio L; Ronchi M; Giunta A
    J Pediatr; 1990 Sep; 117(3):482-9. PubMed ID: 2391610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of an oral ursodeoxycholic acid load in the assessment of bile acid malabsorption in cystic fibrosis.
    Colombo C; Roda A; Roda E; Piceni Sereni L; Maspero D; Giunta AM; Barbara L
    Dig Dis Sci; 1983 Apr; 28(4):306-11. PubMed ID: 6831994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pharmacokinetic analysis of enterohepatic circulation of ursodeoxycholic acid, a drug with a high hepatic extraction but a small clearance.
    Kubota K; Yamaoka K; Ishizaki T; Makino I; Shinozaki K; Yamaguchi A; Nakagawa S
    Res Commun Chem Pathol Pharmacol; 1988 Nov; 62(2):309-26. PubMed ID: 3251339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of portal and splenic vein shunts and impaired hepatic extraction in the elevated serum bile acids in liver cirrhosis.
    Ohkubo H; Okuda K; Iida S; Ohnishi K; Ikawa S; Makino I
    Gastroenterology; 1984 Mar; 86(3):514-20. PubMed ID: 6693014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular bile acid transport and ursodeoxycholic acid hypercholeresis.
    Scharschmidt BF; Lake JR
    Dig Dis Sci; 1989 Dec; 34(12 Suppl):5S-15S. PubMed ID: 2689116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of iso-ursodeoxycholic acid during administration of ursodeoxycholic acid in man.
    Beuers U; Fischer S; Spengler U; Paumgartner G
    J Hepatol; 1991 Jul; 13(1):97-103. PubMed ID: 1918882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and metabolism of [14C]ursodeoxycholic acid in the rat.
    Parquet M; Rey C; Groussard M; Infante R
    Biochim Biophys Acta; 1981 Aug; 665(2):299-305. PubMed ID: 7284427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis.
    Matsuzaki Y; Tanaka N; Osuga T; Aikawa T; Shoda J; Doi M; Nakano M
    Am J Gastroenterol; 1990 Jan; 85(1):15-23. PubMed ID: 1967512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile acid conjugation in early stage cholestatic liver disease before and during treatment with ursodeoxycholic acid.
    Fracchia M; Setchell KD; Crosignani A; Podda M; O'Connell N; Ferraris R; Hofmann AF; Galatola G
    Clin Chim Acta; 1996 Apr; 248(2):175-85. PubMed ID: 8740581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormality of oral ursodeoxycholic acid tolerance test in the Dubin-Johnson syndrome.
    Kawasaki H; Yamanishi Y; Kishimoto Y; Hirayama C; Ikawa S; Kuchiba K; Kondo T
    Clin Chim Acta; 1981 Apr; 112(1):13-9. PubMed ID: 7237821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of a phase I multiple-dose clinical study of ursodeoxycholic Acid.
    Hess LM; Krutzsch MF; Guillen J; Chow HH; Einspahr J; Batta AK; Salen G; Reid ME; Earnest DL; Alberts DS
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):861-7. PubMed ID: 15159320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ursodeoxycholic acid (UDCA) on pancreatic enzyme secretion and gallbladder emptying.
    Lanzini A; Hall N; Facchinetti D; Northfield TC
    Pancreas; 1990 Mar; 5(2):128-35. PubMed ID: 2315289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. delta 22-Ursodeoxycholic acid, a unique metabolite of administered ursodeoxycholic acid in rats, indicating partial beta-oxidation as a major pathway for bile acid metabolism.
    Setchell KD; Yamashita H; Rodrigues CM; O'Connell NC; Kren BT; Steer CJ
    Biochemistry; 1995 Apr; 34(13):4169-78. PubMed ID: 7703228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of ursodeoxycholic acid on the biliary lipids secretion (author's transl)].
    Yanaura S; Izuka A; Ishikawa S
    Nihon Yakurigaku Zasshi; 1981 Oct; 78(4):261-7. PubMed ID: 7327454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.